Merck
MRK
$111.07
Share price
-1.10%
Change (1 day)
20.69%
Change (1 year)
Categories
Merck (MRK) - Cash on Hand
Cash on Hand as of December 2022 : $13.19 B
According to Merck's latest financial reports the company has $13.19 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Merck - Cash on Hand chart (from 2001 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $13.19 B | 62.94% |
| 2021-12-31 | $8.09 B | 0.42% |
| 2020-12-31 | $8.06 B | -22.85% |
| 2019-12-31 | $10.45 B | 17.89% |
| 2018-12-31 | $8.86 B | 4.31% |
| 2017-12-31 | $8.49 B | -40.74% |
| 2016-12-31 | $14.34 B | 6.81% |
| 2015-12-31 | $13.42 B | -14.58% |
| 2014-12-31 | $15.71 B | -10.11% |
| 2013-12-31 | $17.48 B | 8.33% |
| 2012-12-31 | $16.14 B | 7.81% |
| 2011-12-31 | $14.97 B | 22.71% |
| 2010-12-31 | $12.20 B | 27.03% |
| 2009-12-31 | $9.60 B | 75.06% |
| 2008-12-31 | $5.48 B | -33.34% |
| 2007-12-31 | $8.23 B | -5.53% |
| 2006-12-31 | $8.71 B | -44.28% |
| 2005-12-31 | $15.63 B | 120.56% |
| 2004-12-31 | $7.08 B | 69.9% |
| 2003-12-31 | $4.17 B | -16.06% |
| 2002-12-31 | $4.97 B | 51.26% |
| 2001-12-31 | $3.28 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $23.51 B | 78.28% | 🇺🇸 USA |
 Novartis NVS | $12.26 B | -7.06% | 🇨🇭 Switzerland |
 Pfizer PFE | $22.73 B | 72.32% | 🇺🇸 USA |
 Abbott Laboratories ABT | $10.17 B | -22.91% | 🇺🇸 USA |
 Eli Lilly LLY | $3.66 B | -72.19% | 🇺🇸 USA |
 Amgen AMGN | $31.56 B | 139.24% | 🇺🇸 USA |
 Sanofi SNY | $14.35 B | 8.79% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $8.99 B | -31.81% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $8.64 B | -34.50% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $2.80 B | -78.77% | 🇮🇱 Israel |